tiprankstipranks
Advertisement
Advertisement

SBMFF Stock Latest News

Sino Biopharm’s Bispecific Antibody M701 Shows Promise in Malignant Effusion Trials
Company AnnouncementsSino Biopharm’s Bispecific Antibody M701 Shows Promise in Malignant Effusion Trials
19h ago
Sino Biopharmaceutical Wins China First-Line Approval for Oral HER2 Lung Cancer Drug
PremiumCompany Announcements
Sino Biopharmaceutical Wins China First-Line Approval for Oral HER2 Lung Cancer Drug
1d ago
Sino Biopharm Showcases Promising Obesity Antibody Data and Expands Weight-Loss Pipeline
PremiumCompany Announcements
Sino Biopharm Showcases Promising Obesity Antibody Data and Expands Weight-Loss Pipeline
9d ago
GSK enters into exclusive strategic collaboration with Sino Biopharm
PremiumThe Fly
GSK enters into exclusive strategic collaboration with Sino Biopharm
11d ago
GSK
Sino Biopharm, GSK in exclusive China pact for breakthrough hepatitis B drug
PremiumCompany Announcements
Sino Biopharm, GSK in exclusive China pact for breakthrough hepatitis B drug
12d ago
Sino Biopharm Wins NMPA Review Nod for First Domestic CD3/EpCAM Bispecific Antibody
PremiumCompany AnnouncementsSino Biopharm Wins NMPA Review Nod for First Domestic CD3/EpCAM Bispecific Antibody
15d ago
Sino Biopharm Advances First-in-Class CCR8 Antibody Into Phase III Gastric Cancer Trial
Premium
Company Announcements
Sino Biopharm Advances First-in-Class CCR8 Antibody Into Phase III Gastric Cancer Trial
16d ago
Sino Biopharmaceutical Wins China Nod for First-Line Use of Novel Breast Cancer Drug
Premium
Company Announcements
Sino Biopharmaceutical Wins China Nod for First-Line Use of Novel Breast Cancer Drug
16d ago
Sino Biopharmaceutical Plans Board Changes Ahead of 2026 AGM
PremiumCompany Announcements
Sino Biopharmaceutical Plans Board Changes Ahead of 2026 AGM
23d ago
Sino Biopharm Sets Hybrid AGM, Seeks Fresh Share Issue Mandate
PremiumCompany Announcements
Sino Biopharm Sets Hybrid AGM, Seeks Fresh Share Issue Mandate
23d ago
Sino Biopharmaceutical Bolsters Leadership for Global Clinical Development
PremiumCompany Announcements
Sino Biopharmaceutical Bolsters Leadership for Global Clinical Development
24d ago
Sino Biopharm Unit LaNova Unveils Promising ADC Data at AACR 2026
PremiumCompany Announcements
Sino Biopharm Unit LaNova Unveils Promising ADC Data at AACR 2026
1M ago
Sino Biopharm Wins China Approval for New Alveolar Soft Part Sarcoma Therapy
PremiumCompany AnnouncementsSino Biopharm Wins China Approval for New Alveolar Soft Part Sarcoma Therapy
1M ago
Sino Biopharm Reports Promising Early Data for PD-1/VEGF Bispecific Cancer Drug Licensed to Merck
Premium
Company Announcements
Sino Biopharm Reports Promising Early Data for PD-1/VEGF Bispecific Cancer Drug Licensed to Merck
1M ago
Sino Biopharm Advances CLDN18.2 ADC With First Patient Dosed in Global Phase III Gastric Cancer Trial
Premium
Company Announcements
Sino Biopharm Advances CLDN18.2 ADC With First Patient Dosed in Global Phase III Gastric Cancer Trial
1M ago
Sino Biopharm Advances Kylo-11 With First U.S. Patient in Phase II Trial
PremiumCompany Announcements
Sino Biopharm Advances Kylo-11 With First U.S. Patient in Phase II Trial
1M ago
Sino Biopharm Wins Early Greater Bay Area Nod for Naldemedine in Opioid-Induced Constipation
PremiumCompany Announcements
Sino Biopharm Wins Early Greater Bay Area Nod for Naldemedine in Opioid-Induced Constipation
1M ago
Sino Biopharm Wins FDA IND Nod for Pan-KRAS Cancer Drug TQB3205
PremiumCompany Announcements
Sino Biopharm Wins FDA IND Nod for Pan-KRAS Cancer Drug TQB3205
1M ago
Sino Biopharmaceutical Completes Hygieia Acquisition With Performance-Linked Payout Structure
PremiumCompany Announcements
Sino Biopharmaceutical Completes Hygieia Acquisition With Performance-Linked Payout Structure
2M ago
Sino Biopharm Buys HK$27 Million in Shares for Award Scheme
PremiumCompany AnnouncementsSino Biopharm Buys HK$27 Million in Shares for Award Scheme
2M ago
Sino Biopharm lifts profit on surging innovative drug sales in 2025
Premium
Company Announcements
Sino Biopharm lifts profit on surging innovative drug sales in 2025
2M ago
Sino Biopharm Proposes HKD 0.05 Final Dividend for 2025
Premium
Company Announcements
Sino Biopharm Proposes HKD 0.05 Final Dividend for 2025
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >